1/3/2023 0 Comments Emex 3 3.11.1661![]() ![]() Median PR-OS was significantly better for patients in complete (17.8 months 95% CI, 7.9-41.6) vs partial remission at auto-HCT (7.1 months 95% CI, 5.4-11 P =. Median PR-OS of all relapsed DLBCL patients after auto-HCT (n = 228) was 9.8 months (95% confidence interval, 7-15). Of the 700 patients with DLBCL who underwent auto-HCT, 248 (35%) relapsed after auto-HCT. Secondary end points were factors prognostic of PR-OS. The primary end point was postrelapse overall survival (PR-OS). Eligibility criteria included adult patients (age ≥18 years) with DLBCL experiencing disease relapse after auto-HCT performed during 2006 to 2015. We studied outcomes of such patients using data from 4 transplantation centers. ![]() Outcomes for diffuse large B-cell lymphoma (DLBCL) patients relapsing after autologous hematopoietic cell transplantation (auto-HCT) have been historically poor. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |